These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 16166967)
1. Optical technologies for cervical neoplasia: update of an NCI program project grant. Follen M; Crain S; MacAulay C; Basen-Engquist K; Cantor SB; Cox D; Atkinson EN; MacKinnon N; Guillaud M; Richards-Kortum R Clin Adv Hematol Oncol; 2005 Jan; 3(1):41-53. PubMed ID: 16166967 [TBL] [Abstract][Full Text] [Related]
2. DNA ploidy compared with human papilloma virus testing (Hybrid Capture II) and conventional cervical cytology as a primary screening test for cervical high-grade lesions and cancer in 1555 patients with biopsy confirmation. Guillaud M; Benedet JL; Cantor SB; Staerkel G; Follen M; MacAulay C Cancer; 2006 Jul; 107(2):309-18. PubMed ID: 16773634 [TBL] [Abstract][Full Text] [Related]
4. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
5. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Saraiya M; Irwin KL; Carlin L; Chen X; Jain N; Benard V; Montano DE Cancer; 2007 Sep; 110(5):1024-32. PubMed ID: 17628488 [TBL] [Abstract][Full Text] [Related]
6. Cervical cancer: the sub-Saharan African perspective. Anorlu RI Reprod Health Matters; 2008 Nov; 16(32):41-9. PubMed ID: 19027621 [TBL] [Abstract][Full Text] [Related]
7. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004. Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831 [TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus testing for primary cervical cancer screening. Grce M; Davies P Expert Rev Mol Diagn; 2008 Sep; 8(5):599-605. PubMed ID: 18785808 [TBL] [Abstract][Full Text] [Related]
9. Optical technologies and molecular imaging for cervical neoplasia: a program project update. Buys TP; Cantor SB; Guillaud M; Adler-Storthz K; Cox DD; Okolo C; Arulogon O; Oladepo O; Basen-Engquist K; Shinn E; Yamal JM; Beck JR; Scheurer ME; van Niekerk D; Malpica A; Matisic J; Staerkel G; Atkinson EN; Bidaut L; Lane P; Benedet JL; Miller D; Ehlen T; Price R; Adewole IF; MacAulay C; Follen M Gend Med; 2012 Feb; 9(1 Suppl):S7-24. PubMed ID: 21944317 [TBL] [Abstract][Full Text] [Related]
10. Preventing cervical cancer : overviews of the National Breast and Cervical Cancer Early Detection Program and 2 US immunization programs. Khan K; Curtis CR; Ekwueme DU; Stokley S; Walker C; Roland K; Benard V; Saraiya M Cancer; 2008 Nov; 113(10 Suppl):3004-12. PubMed ID: 18980296 [TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. Trottier H; Franco EL Am J Manag Care; 2006 Dec; 12(17 Suppl):S462-72. PubMed ID: 17203990 [TBL] [Abstract][Full Text] [Related]
13. The Special Populations Networks for cancer awareness research and training. Chu KC; Jackson FE Pac Health Dialog; 2004 Sep; 11(2):222-4. PubMed ID: 16281704 [TBL] [Abstract][Full Text] [Related]
14. Objective screening for cervical cancer in developing nations: lessons from Nigeria. Roblyer D; Richards-Kortum R; Park SY; Adewole I; Follen M Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S94-7. PubMed ID: 17825396 [TBL] [Abstract][Full Text] [Related]
15. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience. SepĂșlveda C; Prado R Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399 [TBL] [Abstract][Full Text] [Related]
16. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691 [TBL] [Abstract][Full Text] [Related]
17. Cervical cancer prevention in the human papilloma virus vaccine era. Ghazal-Aswad S Ann N Y Acad Sci; 2008 Sep; 1138():253-6. PubMed ID: 18837904 [TBL] [Abstract][Full Text] [Related]
18. Lessons from the history of tobacco harm reduction: The National Cancer Institute's Smoking and Health Program and the "less hazardous cigarette". Parascandola M Nicotine Tob Res; 2005 Oct; 7(5):779-89. PubMed ID: 16191749 [TBL] [Abstract][Full Text] [Related]
19. Cervical cancer in the developing world. Zeferino LC; Derchain SF Best Pract Res Clin Obstet Gynaecol; 2006 Jun; 20(3):339-54. PubMed ID: 16563869 [TBL] [Abstract][Full Text] [Related]
20. Low cost methods for secondary prevention of cervical cancer in developing countries. Anorlu RI; Ola ER; Abudu OO Niger Postgrad Med J; 2007 Sep; 14(3):242-6. PubMed ID: 17767211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]